| A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna™ Gene Signature Assay (NCT01974856) | NanoString Technologies, Inc. | 2013-10-01 |
| Immediate Implant Breast Reconstruction (NCT02055937) | Institut du Cancer de Montpellier - Val d'Aurelle | 2013-10-01 |
| Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients (NCT01809171) | Universitaire Ziekenhuizen KU Leuven | 2013-10-01 |
| PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer (NCT01973660) | SOLTI Breast Cancer Research Group | 2013-10-01 |
| Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast Cancer (NCT01980823) | Columbia University | 2013-10-01 |
| Improving Adherence to Recommended Surveillance in Breast Cancer Survivors (NCT02189278) | Duke University | 2013-10-01 |
| REduction of Physical Inactivity Facing the CAncer (NCT02867475) | Centre Antoine Lacassagne | 2013-10-01 |
| Intrapleural AdV-tk Therapy in Patients With Malignant Pleural Effusion (NCT01997190) | Candel Therapeutics, Inc. | 2013-10-01 |
| The Effect of an Inter-Disciplinary Program, Including MBSR, in Breast Cancer Survivors With Chronic Neuropathic Pain (NCT02125006) | Ottawa Hospital Research Institute | 2013-10-01 |
| Utrecht Cohort for Multiple Breast Cancer Intervention Studies and Long-term Evaluation - The UMBRELLA Cohort (NCT02839863) | UMC Utrecht | 2013-10-01 |
| Surveillance Imaging Modalities for Breast Cancer Assessment (NCT02212834) | Kaiser Permanente | 2013-10-01 |
| Effectiveness of Accelerated Intervention With Compression Sleeve in Mild and Moderate Breast Cancer-related Lymphedema (NCT01954654) | Mette Brodersen Jerver | 2013-10-01 |
| Collection of Blood Specimens for Circulating Tumor Cell Analysis (NCT01943500) | Viatar LLC | 2013-09-30 |
| Brain Functional MRI in Older Women With Breast Cancer (Brain fMRI-BC) (NCT01992432) | City of Hope Medical Center | 2013-09-30 |
| Phase Ib Trial of Two Folate Binding Protein Peptide Vaccines (E39 and J65) in Breast and Ovarian Cancer Patients (NCT02019524) | COL George Peoples, MD, FACS | 2013-09-30 |
| Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer) (NCT01881230) | Celgene | 2013-09-26 |
| Eribulin Versus Vinorelbine in Subjects With Locally Recurrent or Metastatic Breast Cancer Previously Treated With Anthracyclines and Taxanes (NCT02225470) | Eisai Co., Ltd. | 2013-09-26 |
| Monoclonal Antibodies Elimination in Breast Cancer Patient (NCT02855775) | Centre Hospitalier Universitaire de Besancon | 2013-09-25 |
| Phase III to Evaluate Patient´s Preference of Subcutaneous Trastuzumab vs Intravenous in HER2+ Advanced Breast Cancer (NCT01875367) | Spanish Breast Cancer Research Group | 2013-09-18 |
| Trastuzumab Combined With Chemotherapy or Endocrine Therapy to Treat Metastatic Luminal B2 Breast Cancer (NCT01950182) | Sun Yat-sen University | 2013-09-16 |
| S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (NCT01674140) | SWOG Cancer Research Network | 2013-09-12 |
| Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment (NCT01573442) | Alliance for Clinical Trials in Oncology | 2013-09-10 |
| Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer (NCT01857193) | Novartis Pharmaceuticals | 2013-09-06 |
| An Investigation of Chemotherapy Induced Cognitive Impairments in Breast Cancer Survivors (NCT02515487) | NYU Langone Health | 2013-09-01 |
| Phase I Study of Lurbinectedin (PM01183) in Combination With Paclitaxel, With or Without Bevacizumab, in Selected Advanced Solid Tumors (NCT01831089) | PharmaMar | 2013-09-01 |
| Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer (NCT01926964) | Swiss Cancer Institute | 2013-09-01 |
| Radiofrequency Ablation in Breast Cancer (NCT02281812) | Hospital Universitari de Bellvitge | 2013-09-01 |
| The Impact of a Patient Education Intervention for Ambulatory Oncology Patients (NCT02038114) | Sunnybrook Health Sciences Centre | 2013-09-01 |
| Feasibility of Blood Oxygenation Level-Dependent Contrast (BOLD) Breast MRI Induced by Breath- Holding (NCT01898533) | Duke University | 2013-09-01 |
| Effect of Midazolam Premedication Before Induction on the Functional Recovery After General Anesthesia in the Patients Undergoing Breast Surgery Due to Breast Cancer (NCT01945476) | Yonsei University | 2013-09-01 |
| An Open-Label Study of a Novel JAK-inhibitor, INCB047986, Given in Patients With Advanced Malignancies (NCT01929941) | Incyte Corporation | 2013-09-01 |
| Hula, a Physical Activity Intervention for Female-Cancer Survivors (NCT02351479) | University of Hawaii | 2013-09-01 |
| Effect of PPARγ2 Polymorphism and NSAIDs on Acute Alcohol-induced Changes in Serum Estrogens Among Post-menopausal Women (NCT02463383) | Professor Lars Ove Dragsted | 2013-09-01 |
| Improving Care After Chemotherapy (NCT01944137) | Massachusetts General Hospital | 2013-09-01 |
| REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy (NCT01984138) | Polly A. Niravath, MD | 2013-09-01 |
| Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients (NCT01939054) | Chinese Academy of Medical Sciences | 2013-09-01 |
| Safety and Efficacy of HO/02/02 20µg vs. SoC (Aloe Vera) to Reduce Radiation Dermatitis (NCT01923220) | HealOr | 2013-09-01 |
| Yoga for Aromatase Inhibitor-associated Joint Pain (NCT01951976) | H. Lee Moffitt Cancer Center and Research Institute | 2013-09-01 |
| Accessory Joint and Neural Mobilizations in Shoulder After Breast Cancer Surgery. Randomized Clinical Trial. (NCT02366793) | University of Alcala | 2013-09-01 |
| Chemotherapy Effect on Brain Structure, Neurophysiology and Psychomotor Behavior in Breast Cancer Patients (NCT02896504) | Kessler Foundation | 2013-09-01 |
| Circulating Tumor DNA to Monitor Response to Neoadjuvant Chemotherapy in Breast Cancer (NCT03260192) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2013-09-01 |
| Evaluation of Cabazitaxel in Patients With Brain Metastasis Secondary to Breast Cancer and NSCLC (NCT01913067) | Jules Bordet Institute | 2013-09-01 |
| A Study of Subcutaneously Administered Herceptin (Trastuzumab) in Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (NCT01928615) | Hoffmann-La Roche | 2013-09-01 |
| PROSPR/PCIPS Project 3: Communication of Personalized Breast Cancer Risk (NCT01879189) | University of Pennsylvania | 2013-09-01 |
| Assessment of Paclitaxel-Induced Neuropathy (NCT01953159) | University of Chicago | 2013-08-29 |
| Capecitabine + Bendamustine in Women With Pretreated Locally Advanced or Metastatic Her2-negative Breast Cancer (NCT01891227) | Arbeitsgemeinschaft medikamentoese Tumortherapie | 2013-08-09 |
| NEXT (Nutrition and EXercise During Adjuvant Treatment) Study (NCT01806181) | University of British Columbia | 2013-08-06 |
| A Study to Evaluate Lumretuzumab in Combination With Pertuzumab and Paclitaxel in Participants With Metastatic Breast Cancer Expressing Human Epidermal Growth Factor Receptor (HER) 3 and HER2 Protein (NCT01918254) | Hoffmann-La Roche | 2013-08-06 |
| Fat Metabolism Following Chemotherapy in Breast Cancer (NCT01890824) | Texas A&M University | 2013-08-01 |
| Physical Activity to Reduce Joint Pain During Aromatase Inhibitor Therapy (NCT01900418) | University of North Carolina, Chapel Hill | 2013-08-01 |
| Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry (NCT02443428) | Eisai Limited | 2013-08-01 |
| Intensive Education in Increasing Understanding of Lymphedema in Patients With Breast Cancer Undergoing Surgery (NCT02073045) | Case Comprehensive Cancer Center | 2013-08-01 |
| A Continuing Cancer Service Model Emphasizing on Functional Restoration: Model for Breast Cancer (NCT01963572) | National Taiwan University Hospital | 2013-08-01 |
| Evaluation of Response to Two Schedules of Capecitabine in Patients With Metastatic Breast Cancer (NCT02028494) | Latin American & Caribbean Society of Medical Oncology | 2013-08-01 |
| Diffusion Weighted MR Imaging of the Breasts in Women at High Risk of Breast Cancer: A Pilot Study (NCT01938157) | University of North Carolina, Chapel Hill | 2013-08-01 |
| Effects of Yoga on Menopausal Symptoms in Women With Breast Cancer (NCT01908270) | Universität Duisburg-Essen | 2013-08-01 |
| Clinical Trial of The Use of Bolus in Post Mastectomy Irradiation in Breast Cancer (NCT01925651) | AC Camargo Cancer Center | 2013-08-01 |
| Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy (NCT01855607) | Columbia University | 2013-08-01 |
| CROSSROAD II: Activating Rural Clinics and Women With Disabilities to Improve Cancer Screening (NCT01773980) | OHSU Knight Cancer Institute | 2013-08-01 |
| Persistant Organics Pollutants in Breast Cancer. (NCT03788187) | European Georges Pompidou Hospital | 2013-08-01 |
| Fluorestradiol (FES) PET/CT for Imaging Estrogen Receptor Status (NCT01916122) | Memorial Sloan Kettering Cancer Center | 2013-08-01 |
| Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa (NCT01796197) | Dana-Farber Cancer Institute | 2013-08-01 |
| Pre-Operative Radiation and Veliparib for Breast Cancer (NCT01618357) | Richard Zellars | 2013-07-22 |
| Survivorship Care Planning in Improving the Quality of Life in Breast Cancer Survivors (NCT01824745) | City of Hope Medical Center | 2013-07-15 |
| Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers (NCT02600442) | Assistance Publique - Hôpitaux de Paris | 2013-07-01 |
| Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study (NCT02562170) | Medical University of Vienna | 2013-07-01 |
| At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions (NCT01931644) | Sanguine Biosciences | 2013-07-01 |
| Surveillance Markers of Utility for Recurrence After Neoadjuvant Chemotherapy for Breast Cancer (NCT02830282) | Abramson Cancer Center at Penn Medicine | 2013-07-01 |
| Abiraterone Acetate in Molecular Apocrine Breast Cancer (NCT01842321) | UNICANCER | 2013-07-01 |
| A Prospective Cohort Study Evaluating Risk of Local Recurrence Following Breast Conserving Surgery and Endocrine Therapy in Low Risk Luminal A Breast Cancer (NCT01791829) | Ontario Clinical Oncology Group (OCOG) | 2013-07-01 |
| Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer (NCT01898117) | The Netherlands Cancer Institute | 2013-07-01 |
| Identification and Evaluation of Biomarkers of Resistance to Neoadjuvant Chemotherapy (IDEA SEIN) (NCT03255486) | Institut du Cancer de Montpellier - Val d'Aurelle | 2013-07-01 |
| Evaluation of Two Techniques for the SLN Detection in BC Patients (NCT02032498) | Jules Bordet Institute | 2013-07-01 |
| NSABP Biospecimen Discovery Project (NCT01850628) | NSABP Foundation Inc | 2013-07-01 |
| Effectiveness of Acupuncture in Post-Mastectomy Patients With Tissue Expanders (NCT02639611) | NYU Langone Health | 2013-07-01 |
| Efficacy and Safety of Dignicap System for Preventing Chemotherapy Induced Alopecia (NCT01831024) | Target Health Inc. | 2013-07-01 |
| NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer (NCT01931163) | Jenny C. Chang, MD | 2013-07-01 |
| Whole Breast Irradiation vs Twice Daily vs. Once Daily Accelerated Partial Breast Irradiation (NCT03616626) | National Cancer Institute, Egypt | 2013-07-01 |
| Dose Escalation Study MORAb-066 Targeting Tissue Factor (TF)-Expressing Malignancies Including Breast, Pancreatic, Colorectal, NSCLC (NCT01761240) | Morphotek | 2013-06-19 |
| HELENA Study: An Observational Study of Perjeta (Pertuzumab) in First-Line Treatment in Patients With Her2-Positive Advanced Breast Cancer After Adjuvant Herceptin Therapy (NCT01777958) | Hoffmann-La Roche | 2013-06-14 |
| Breast Tissue Study of Breast Diseases Among Women in Hong Kong (NCT01885039) | National Cancer Institute (NCI) | 2013-06-12 |
| A Study to Assess Preference for Subcutaneous Trastuzumab Treatment in Participants With Human Epidermal Growth Factor Receptor (HER)2-Positive Metastatic Breast Cancer Responding to First-Line Intravenous Trastuzumab for at Least 3 Years (NCT01810393) | Hoffmann-La Roche | 2013-06-11 |
| FES-PET for Patients Treated on NCI Protocol 8762 (NCT01714128) | Washington University School of Medicine | 2013-06-01 |
| 2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer (NCT02460744) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2013-06-01 |
| A Prospective Study to Evaluate the Effect of Systemic Adjuvant Therapy on the Cognitive Function of Breast Cancer Patients (NCT01596439) | National University Hospital, Singapore | 2013-06-01 |
| Effects of a Structured Exercise Program on Cancer-Related Fatigue in Women Receiving Radiation Therapy for Breast Cancer (NCT02117011) | Georgetown University | 2013-06-01 |
| A Prospective Observational Study of Clinical Outcomes for the NanoString® Technologies Prosigna Gene Signature Assay (NCT01899079) | NanoString Technologies, Inc. | 2013-06-01 |
| Cyberknife After Breast Conservative Surgery (NCT02896322) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2013-06-01 |
| CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer (NCT02918084) | IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy | 2013-06-01 |
| Breast Lymph Node Mapping (NCT01038908) | University of British Columbia | 2013-06-01 |
| Mild Cognitive Impairment in Breast Cancer Patients (NCT01949376) | Northwestern University | 2013-06-01 |
| Explore the Individual Treatment of Docetaxel and Paclitaxel in NSCLC, NPC and BRC by PK-guided Dosing Strategy (NCT01891123) | Sun Yat-sen University | 2013-06-01 |
| Study of Neoadjuvant Myocet®, Paclitaxel, Pertuzumab, and Trastuzumab in HER2-positive Breast Cancer (NCT01669239) | SOLTI Breast Cancer Research Group | 2013-06-01 |
| Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early Breast Cancer - Triple Negative Breast Cancer (NCT01815242) | Women's Cancer Study Group GmbH | 2013-06-01 |
| Eribulin Mesylate Phase IV Clinical Trial in Korean Patients With Metastatic or Locally Advanced Breast Cancer (NCT01961544) | Eisai Korea Inc. | 2013-06-01 |
| Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax (NCT01570036) | George E. Peoples | 2013-05-21 |
| S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy (NCT01598298) | SWOG Cancer Research Network | 2013-05-15 |
| Effect of a Program of Physical Activity and Nutritional Therapeutic Education in Breast Cancer Patients (NCT04109326) | Institut du Cancer de Montpellier - Val d'Aurelle | 2013-05-15 |
| The Effect of Yoga Therapy on Post-operative Side-effects Among Women With Breast Cancer (NCT05820373) | The University of Hong Kong | 2013-05-14 |
| Internet-Delivered Cognitive Training For Breast Cancer Survivors With Cognitive Complaints (NCT01866813) | University of Aarhus | 2013-05-01 |